The amount of Americans undergoing routine cancer screenings has plummeted during the pandemic, according to Epic data cited by STAT.
Oncology
The costs of dozens of cancer drugs were about 2.3 times higher in the U.S. than in Europe even though they had similar clinical benefits, according to a study cited by STAT.
Researchers at Danville, Pa.-based Geisinger have successfully used a blood test to diagnose presymptomatic cancer patients for the first time, according to a study published in Science.
Grisel Fernandez-Bravo, DNP, CEO of Memorial Hospital Miramar (Fla.), has had to find new ways to manage operations after treatment for her cancer diagnosis left her immunocompromised and susceptible to COVID-19.
Advertisement
New research shows that cancer patients who contract COVID-19 are nearly three times more likely to die that COVID-19 patients who do not have cancer, a new study shows.
Memphis, Tenn.-based St. Jude Children's Research Hospital partnered with the International Society of Paediatric Oncology to launch a global COVID-19 data registry and resource center for pediatric cancer.
AstraZeneca will start a clinical trial to see if its cancer drug Calquence can suppress the excessive immune response COVID-19 triggers in some patients, the drugmaker said April 14.
U.S. cancer patients experience differences in survival rates in accordance with their race or ethnic group, a study published in JAMA Network Open shows.
With federal and state governments loosening restrictions on telemedicine due to the coronavirus pandemic, hospitals such as Tampa, Fla.-based Moffitt Cancer Center have reported steep increases in virtual visits with patients.